Clinical Trials Logo

Clinical Trial Summary

Lung neuroendocrine tumor (LNT) represents approximately 20% of all lung cancers. The classification of LNT relies upon morphology. Recently, in the World Health Organization (WHO) classification, Ki-67 rate has been proposed for classi fication. It is, however, known that Ki-67 count has a poor interlaboratory reproducibly. For that reason, our team has looked for a new biomarker.

GLUT1 protein a facilitative glucose transporter protein which has ubiquitous expression in mammalian. GLUT1 is overexpressed in many human cancers. But, no study has evaluated the GLUT1 staining as an aid diagnosis in LNT.

The team have assessed the GLUT1 immunohistochemical staining in 36 LNT and to assess its diagnostic value.


Clinical Trial Description

The (LNT) Lung neuroendocrine tumor represents approximately 20% of all lung cancers. The classification of LNT relies upon morphology. Recently, in the World Health Organization (WHO) classification, Ki-67 rate has been proposed for classi fication. It is, however, known that Ki-67 count has a poor interlaboratory reproducibly. For that reason, our team has looked for a new biomarker.

GLUT1 protein a facilitative glucose transporter protein which has ubiquitous expression in mammalian. GLUT1 is overexpressed in many human cancers. But, no study has evaluated the GLUT1 staining as an aid diagnosis in LNT. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03645915
Study type Observational
Source Centre Hospitalier Universitaire, Amiens
Contact
Status Completed
Phase
Start date January 1, 2014
Completion date November 13, 2016

See also
  Status Clinical Trial Phase
Completed NCT02939729 - Physiotherapy Prehabilitation in Patients Undergoing Cardiac or Thoracic Surgery N/A
Completed NCT02559349 - Gut Microbiota And Radiotherapy
Completed NCT02862288 - Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia. Phase 1/Phase 2
Recruiting NCT04056273 - Assess the Use of rEBUS With a Guide Sheath to Increase Transbronchial Lung Biopsy Yield Rate N/A
Recruiting NCT03528733 - Feasibility of Multi-Energy Digital Radiography Detector for Lung Lesions Detection N/A
Completed NCT03972228 - Microdevice for Evaluating Drug Response in Site in Lung Lesions Early Phase 1
Not yet recruiting NCT06397807 - Postoperative Pain Management on Patients Undergoing Lung Tumor Resection
Withdrawn NCT04917224 - Study of LUNG Stereotactic Adaptive Ablative Radiotherapy N/A
Active, not recruiting NCT03881410 - The Efficacy of Shear-wave Elastography-guided Aspiration and Biopsy for Diagnosis in Lung Tumor N/A
Not yet recruiting NCT05279521 - The Effect of Interventional Pulmonary Rehabilitation Exercise With Advanced Lung Cancer. N/A
Recruiting NCT06322329 - RealMove (Lung): Assessing Tumour Motion With Dynamic MRI N/A
Active, not recruiting NCT05169437 - Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors Phase 2
Completed NCT01394978 - NeoMend ProGELâ„¢ Pleural Air Leak Sealant Post-Approval Study N/A
Recruiting NCT04974632 - Mobile 3D C-arm CT for Lung Tumor Localization Efficacy Analysis: a Prospective Clinical Trial N/A
Active, not recruiting NCT05555342 - A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-Arm Early Phase 1
Completed NCT01388803 - The Depth of Right Bronchial Blocker Placement in Taiwanese in Video-assisted Thoracoscopic Surgery(VATS) N/A
Recruiting NCT04075305 - The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study